The Patent Finder

Terms ending in 2027

Acceleron Pharma Inc.

Every in-force patent on Acceleron Pharma Inc.'s record whose computed term ends in 2027, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 7,612,041An Isolated Activin-Binding Actriia Polypeptide Comprising the Seq Id No: 7 and Uses for Promoting Bone Growth
In force
 · High confidence
Acceleron Pharma Inc.In forceHigh confidence
US 9,452,197Antagonists of BMP9, BMP10, ALK1 and Other ALK1 Ligands, and Uses Thereof
In force
 · High confidence
Acceleron Pharma, Inc.In forceHigh confidence
US 10,059,756Compositions Comprising ALK1-ECD Protein
In force
 · High confidence
Ludwig Institute for Cancer Research Ltd.In forceHigh confidence
US 12,144,860ALK1 Receptor and Ligand Antagonists and Uses Thereof
In force
 · High confidence
Acceleron Pharma, Inc.In forceHigh confidence
US 7,833,971Uses of Cerberus, Coco and Derivatives Thereof
In force
 · High confidence
Acceleron Pharma Inc.In forceHigh confidence
US 8,007,809Activin-Actrii Antagonists and Uses for Increasing Red Blood Cell Levels
In force
 · Medium confidence
Acceleron Pharma Inc.In forceMedium confidence
US 8,895,016Antagonists of activin-actriia and uses for increasing red blood cell levels
In force
 · Medium confidence
Acceleron Pharma Inc.In forceMedium confidence
7 of 7 patents shown. Soonest term end first, then patent number.
6 of these are in force and held by Acceleron Pharma Inc..
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited